Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Ralph

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
BJU International|July 16, 2017
Sleep disorders in patients with erectile dysfunctionOdunayo Kalejaiye, Amr Abdel Raheem, Amr Moubasher, et al.
The Journal of Urology|January 25, 2003
BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitroJas S Kalsi, Rowland W Rees, Adrian J Hobbs, et al.
European Urology|October 23, 2018
Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease ModelsMarcus M Ilg, Marta Mateus, William J Stebbeds, et al.
Sexual Medicine Reviews|March 23, 2019
A Systematic Review on Ischemic Priapism and Immediate Implantation: Do We Need More Data?Marco Capece, Roberto La Rocca, Vincenzo Mirone, et al.
BJU International|August 24, 2006
Evaluation of the Sexual Assessment Monitor, a diagnostic device used to electronically quantify ejaculatory latency time: findings from three studiesWallace W Dinsmore, David J Ralph, Phillip Kell, et al.
The Journal of Sexual Medicine|August 11, 2020
Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's DiseaseMarcus M Ilg, Simon J Stafford, Marta Mateus, et al.
The Journal of Sexual Medicine|November 13, 2014
Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label studyLaurence A Levine, Beatrice Cuzin, Stephen Mark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinomaOliver J Kayes, Marco Loddo, Nimish Patel, et al.
The Journal of Sexual Medicine|January 15, 2017
Early Effect of Bariatric Surgery on Urogenital Function in Morbidly Obese MenMaha Aleid, Asif Muneer, Sara Renshaw, et al.
BJU International|June 15, 2017
Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocolAmr Abdel Raheem, Marco Capece, Odunayo Kalejaiye, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
BJU International|July 16, 2017
Sleep disorders in patients with erectile dysfunctionOdunayo Kalejaiye, Amr Abdel Raheem, Amr Moubasher, et al.
The Journal of Urology|January 25, 2003
BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitroJas S Kalsi, Rowland W Rees, Adrian J Hobbs, et al.
European Urology|October 23, 2018
Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease ModelsMarcus M Ilg, Marta Mateus, William J Stebbeds, et al.
Sexual Medicine Reviews|March 23, 2019
A Systematic Review on Ischemic Priapism and Immediate Implantation: Do We Need More Data?Marco Capece, Roberto La Rocca, Vincenzo Mirone, et al.
BJU International|August 24, 2006
Evaluation of the Sexual Assessment Monitor, a diagnostic device used to electronically quantify ejaculatory latency time: findings from three studiesWallace W Dinsmore, David J Ralph, Phillip Kell, et al.
The Journal of Sexual Medicine|August 11, 2020
Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's DiseaseMarcus M Ilg, Simon J Stafford, Marta Mateus, et al.
The Journal of Sexual Medicine|November 13, 2014
Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label studyLaurence A Levine, Beatrice Cuzin, Stephen Mark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinomaOliver J Kayes, Marco Loddo, Nimish Patel, et al.
The Journal of Sexual Medicine|January 15, 2017
Early Effect of Bariatric Surgery on Urogenital Function in Morbidly Obese MenMaha Aleid, Asif Muneer, Sara Renshaw, et al.
BJU International|June 15, 2017
Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocolAmr Abdel Raheem, Marco Capece, Odunayo Kalejaiye, et al.
Pageof 14